✅ Öppen
Ingen deadline angiven
Läkemedel Cytostatika 2025
Tidsplan
Publicerad
2025-10-03
Deadline
—
Beskrivning
Tilldelat till: Amgen Aktiebolag, Orifarm AB, Baxter Medical Aktiebolag | Vinnarland: SWE, DNK | Beslutsdatum: 2025-05-23+02:00
Klassificering
CPV-koder
- 33600000 Läkemedel
Procedur
open
Om köparen
Region Blekinge har 14 öppna upphandlingar på Agentanbud just nu, och 59 annonser i vår data.
Köper oftast: Medicinsk utrustning, läkemedel och hygienartiklar · Programvara och informationssystem · IT-tjänster: konsultverksamhet, programvaruutveckling, Internet och stöd.
Flest kontrakt 2021–2024, enligt Upphandlingsmyndighetens statistik över 181 kontrakterade anbud: Abena AB (9) · Essity Hygiene AND Health Aktiebolag (6) · Swereco AB (6).
Liknande öppna upphandlingar
Rådata (JSON)
{
"title-proc": {
"swe": "Läkemedel Cytostatika 2025"
},
"publication-number": "649606-2025",
"contract-conclusion-date": [
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00",
"2025-10-01+02:00"
],
"winner-country": [
"SWE",
"SWE",
"SWE",
"SWE",
"SWE",
"SWE",
"SWE",
"SWE",
"SWE",
"SWE",
"DNK",
"SWE",
"DNK",
"IRL",
"SWE",
"DEU",
"DEU",
"SWE",
"SWE",
"SWE",
"SWE"
],
"organisation-country-buyer": [
"SWE"
],
"framework-agreement-lot": [
"none"
],
"place-of-performance-country-proc": [
"SWE"
],
"winner-identifier": [
"556510-4212",
"556548-7625",
"556654-0653",
"556171-0657",
"556038-3100",
"556622-8937",
"556713-3425",
"009304-1283",
"556517-9305",
"559444-0041",
"2774-4532",
"559485-2252",
"13902992",
"533976",
"556534-0287",
"81530739",
"HRB85786",
"556664-2079",
"556810-0258",
"559065-7085",
"556561-6058"
],
"procedure-type": "open",
"classification-cpv": [
"33600000",
"33600000"
],
"publication-date": "2025-10-03+02:00",
"buyer-name": {
"swe": [
"Region Blekinge"
]
},
"winner-decision-date": [
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00",
"2025-05-23+02:00"
],
"contract-nature-main-proc": "supplies",
"links": {
"xml": {
"MUL": "https://ted.europa.eu/en/notice/649606-2025/xml"
},
"pdf": {
"BUL": "https://ted.europa.eu/bg/notice/649606-2025/pdf",
"SPA": "https://ted.europa.eu/es/notice/649606-2025/pdf",
"CES": "https://ted.europa.eu/cs/notice/649606-2025/pdf",
"DAN": "https://ted.europa.eu/da/notice/649606-2025/pdf",
"DEU": "https://ted.europa.eu/de/notice/649606-2025/pdf",
"EST": "https://ted.europa.eu/et/notice/649606-2025/pdf",
"ELL": "https://ted.europa.eu/el/notice/649606-2025/pdf",
"ENG": "https://ted.europa.eu/en/notice/649606-2025/pdf",
"FRA": "https://ted.europa.eu/fr/notice/649606-2025/pdf",
"GLE": "https://ted.europa.eu/ga/notice/649606-2025/pdf",
"HRV": "https://ted.europa.eu/hr/notice/649606-2025/pdf",
"ITA": "https://ted.europa.eu/it/notice/649606-2025/pdf",
"LAV": "https://ted.europa.eu/lv/notice/649606-2025/pdf",
"LIT": "https://ted.europa.eu/lt/notice/649606-2025/pdf",
"HUN": "https://ted.europa.eu/hu/notice/649606-2025/pdf",
"MLT": "https://ted.europa.eu/mt/notice/649606-2025/pdf",
"NLD": "https://ted.europa.eu/nl/notice/649606-2025/pdf",
"POL": "https://ted.europa.eu/pl/notice/649606-2025/pdf",
"POR": "https://ted.europa.eu/pt/notice/649606-2025/pdf",
"RON": "https://ted.europa.eu/ro/notice/649606-2025/pdf",
"SLK": "https://ted.europa.eu/sk/notice/649606-2025/pdf",
"SLV": "https://ted.europa.eu/sl/notice/649606-2025/pdf",
"FIN": "https://ted.europa.eu/fi/notice/649606-2025/pdf",
"SWE": "https://ted.europa.eu/sv/notice/649606-2025/pdf"
},
"pdfs": {
"SWE": "https://ted.europa.eu/sv/notice/649606-2025/pdfs"
},
"html": {
"BUL": "https://ted.europa.eu/bg/notice/-/detail/649606-2025",
"SPA": "https://ted.europa.eu/es/notice/-/detail/649606-2025",
"CES": "https://ted.europa.eu/cs/notice/-/detail/649606-2025",
"DAN": "https://ted.europa.eu/da/notice/-/detail/649606-2025",
"DEU": "https://ted.europa.eu/de/notice/-/detail/649606-2025",
"EST": "https://ted.europa.eu/et/notice/-/detail/649606-2025",
"ELL": "https://ted.europa.eu/el/notice/-/detail/649606-2025",
"ENG": "https://ted.europa.eu/en/notice/-/detail/649606-2025",
"FRA": "https://ted.europa.eu/fr/notice/-/detail/649606-2025",
"GLE": "https://ted.europa.eu/ga/notice/-/detail/649606-2025",
"HRV": "https://ted.europa.eu/hr/notice/-/detail/649606-2025",
"ITA": "https://ted.europa.eu/it/notice/-/detail/649606-2025",
"LAV": "https://ted.europa.eu/lv/notice/-/detail/649606-2025",
"LIT": "https://ted.europa.eu/lt/notice/-/detail/649606-2025",
"HUN": "https://ted.europa.eu/hu/notice/-/detail/649606-2025",
"MLT": "https://ted.europa.eu/mt/notice/-/detail/649606-2025",
"NLD": "https://ted.europa.eu/nl/notice/-/detail/649606-2025",
"POL": "https://ted.europa.eu/pl/notice/-/detail/649606-2025",
"POR": "https://ted.europa.eu/pt/notice/-/detail/649606-2025",
"RON": "https://ted.europa.eu/ro/notice/-/detail/649606-2025",
"SLK": "https://ted.europa.eu/sk/notice/-/detail/649606-2025",
"SLV": "https://ted.europa.eu/sl/notice/-/detail/649606-2025",
"FIN": "https://ted.europa.eu/fi/notice/-/detail/649606-2025",
"SWE": "https://ted.europa.eu/sv/notice/-/detail/649606-2025"
},
"htmlDirect": {
"BUL": "https://ted.europa.eu/bg/notice/649606-2025/html",
"SPA": "https://ted.europa.eu/es/notice/649606-2025/html",
"CES": "https://ted.europa.eu/cs/notice/649606-2025/html",
"DAN": "https://ted.europa.eu/da/notice/649606-2025/html",
"DEU": "https://ted.europa.eu/de/notice/649606-2025/html",
"EST": "https://ted.europa.eu/et/notice/649606-2025/html",
"ELL": "https://ted.europa.eu/el/notice/649606-2025/html",
"ENG": "https://ted.europa.eu/en/notice/649606-2025/html",
"FRA": "https://ted.europa.eu/fr/notice/649606-2025/html",
"GLE": "https://ted.europa.eu/ga/notice/649606-2025/html",
"HRV": "https://ted.europa.eu/hr/notice/649606-2025/html",
"ITA": "https://ted.europa.eu/it/notice/649606-2025/html",
"LAV": "https://ted.europa.eu/lv/notice/649606-2025/html",
"LIT": "https://ted.europa.eu/lt/notice/649606-2025/html",
"HUN": "https://ted.europa.eu/hu/notice/649606-2025/html",
"MLT": "https://ted.europa.eu/mt/notice/649606-2025/html",
"NLD": "https://ted.europa.eu/nl/notice/649606-2025/html",
"POL": "https://ted.europa.eu/pl/notice/649606-2025/html",
"POR": "https://ted.europa.eu/pt/notice/649606-2025/html",
"RON": "https://ted.europa.eu/ro/notice/649606-2025/html",
"SLK": "https://ted.europa.eu/sk/notice/649606-2025/html",
"SLV": "https://ted.europa.eu/sl/notice/649606-2025/html",
"FIN": "https://ted.europa.eu/fi/notice/649606-2025/html",
"SWE": "https://ted.europa.eu/sv/notice/649606-2025/html"
}
},
"winner-name": {
"swe": [
"Amgen Aktiebolag",
"Orifarm AB",
"Baxter Medical Aktiebolag",
"Roche Aktiebolag",
"Orifarm Generics AB",
"Grindeks Kalceks Sverige AB",
"Sandoz A/S",
"STADA Nordic ApS",
"Biosimilar Collaborations Ireland Limited",
"CAMPUS Pharma AB",
"betapharm Arzneimittel GmbH",
"Accord Healthcare AB",
"Glenmark Pharmaceuticals Nordic AB",
"Fresenius Kabi AB"
]
},
"notice-title": {
"hun": "Svédország – Gyógyszerészeti termékek – Läkemedel Cytostatika 2025",
"lav": "Zviedrija – Farmācijas izstrādājumi – Läkemedel Cytostatika 2025",
"swe": "Sverige – Läkemedel – Läkemedel Cytostatika 2025",
"gle": "An tSualainn – Pharmaceutical products – Läkemedel Cytostatika 2025",
"ell": "Σουηδία – Φαρμακευτικά προϊόντα – Läkemedel Cytostatika 2025",
"spa": "Suecia – Productos farmacéuticos – Läkemedel Cytostatika 2025",
"est": "Rootsi – Ravimid – Läkemedel Cytostatika 2025",
"nld": "Zweden – Farmaceutische producten – Läkemedel Cytostatika 2025",
"fin": "Ruotsi – Farmaseuttiset tuotteet – Läkemedel Cytostatika 2025",
"pol": "Szwecja – Produkty farmaceutyczne – Läkemedel Cytostatika 2025",
"hrv": "Švedska – Farmaceutski proizvodi – Läkemedel Cytostatika 2025",
"ces": "Švédsko – Léčivé přípravky a zdravotnické prostředky – Läkemedel Cytostatika 2025",
"dan": "Sverige – Lægemidler – Läkemedel Cytostatika 2025",
"ron": "Suedia – Produse farmaceutice – Läkemedel Cytostatika 2025",
"por": "Suécia – Produtos farmacêuticos – Läkemedel Cytostatika 2025",
"slk": "Švédsko – Farmaceutické výrobky – Läkemedel Cytostatika 2025",
"fra": "Suède – Produits pharmaceutiques – Läkemedel Cytostatika 2025",
"mlt": "L-Iżvezja – Prodotti farmaċewtiċi – Läkemedel Cytostatika 2025",
"deu": "Schweden – Arzneimittel – Läkemedel Cytostatika 2025",
"lit": "Švedija – Farmacijos produktai – Läkemedel Cytostatika 2025",
"ita": "Svezia – Prodotti farmaceutici – Läkemedel Cytostatika 2025",
"bul": "Швeция – Фармацевтични продукти – Läkemedel Cytostatika 2025",
"slv": "Švedska – Farmacevtski proizvodi – Läkemedel Cytostatika 2025",
"eng": "Sweden – Pharmaceutical products – Läkemedel Cytostatika 2025"
},
"buyer-city": {
"mul": [
"Karlskrona"
]
}
}